Keratoconus therapeutics advances

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

494

HTML

4450

Figures (1-8)

219

Tables (1-3)

229

Sum=5392

Publishing Process of This Article

Item

Count

Browse

1098

Download

892

Sum=1990

Aug 12, 2013 (publication date) through Aug 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Ophthalmology

ISSN

2218-6239

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Therapeutics Advances

World J Ophthalmol. Aug 12, 2013; 3(3): 20-31
Published online Aug 12, 2013. doi: 10.5318/wjo.v3.i3.20

Table 1 Clinical classification of keratoconus[3]

Stage	Characteristics
Stage I	Eccentric bulging
	Induced myopia and/or astigmatism of 5 D
	Average central keratometry of 48 D
Stage II	Induced myopia and/or astigmatism of 5 to 8 D
	Average central keratometry > 48 D but < 53 D
	Absent scarring
	Minimum corneal thickness of 400 microns
Stage III	Induced myopia and/or astigmatism of 8 to 10 D
	Average central keratometry > 53 D
	Absent scarring
	Central corneal thickness of 300 to 400 microns
Stage IV	Invaluable refraction
	Average central keratometry > 55 D
	Central corneal scar
	Corneal thickness < 200 microns

Citation: Jaimes M, Ramirez-Miranda A, Graue-Hernández EO, Navas A. Keratoconus therapeutics advances. World J Ophthalmol 2013; 3(3): 20-31
URL: https://www.wjgnet.com/2218-6239/full/v3/i3/20.htm
DOI: https://dx.doi.org/10.5318/wjo.v3.i3.20